大和:重申吉利(0175.HK)“買入”評級 目標價20港元
大和總研發表研究報告表示,吉利汽車(0175.HK)11月份總銷量為約14.32萬部,按年上升1.1%,當中領克品牌的銷量受低基數所影響增長15%,銷售增長的勢頭持續。該行重申其“買入”評級,維持目標價20港元。
大和指出,吉利今年截至11月底的總銷量達123.15萬部,雖然按年下跌12.5%,但已達到今年全年銷售目標的91%,該行相信吉利可完成其全年銷售目標,並預計其12月銷售受低基數影響而非常強勁。大和續指,隨着行業數據逐漸改善,第四季的情緒將有所改善,預計明年吉利將有強勁的盈利恢復。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.